PMID: 7018801May 1, 1981Paper

Postprandial thermogenesis in obesity

Clinical Science
P S ShettyB A Callingham

Abstract

1. The thermogenic response and changes in plasma substrates and hormones were tested after a liquid meal in lean, obese and formerly obese women. 2. Subjects with a family history of obesity tested either while obese or after slimming to a normal weight had a thermogenic response, which was only half that of the lean group. 3. The immediate response in plasma glucose and insulin was greater in the lean subjects, but the sustained changes in circulating substrates did not differ in the three groups. Thyroidal hormone concentrations did not alter postprandially: venous noradrenaline levels rose in the obese groups only. 4. The differences in postprandial thermogenesis at rest would reduce the energy requirements of subjects with familial obesity, but they still had a metabolic rate estimated to be nearly 1MJ (240 kcal)/day in excess of the lean group so additional thermogenic defects must exist for familial obesity to be explained solely on a metabolic basis.

Citations

Nov 1, 1984·Clinics in Endocrinology and Metabolism·E Jéquier
Mar 1, 1985·Metabolism: Clinical and Experimental·R S SchwartzD C Robbins
Feb 1, 1985·Metabolism: Clinical and Experimental·J BazelmansM D Esler
Jun 1, 1983·Metabolism: Clinical and Experimental·K R Segal, B Gutin
Sep 1, 1990·Metabolism: Clinical and Experimental·K R SegalM B Tomas
Mar 1, 1988·Metabolism: Clinical and Experimental·E Ferrannini
Apr 1, 1992·Metabolism: Clinical and Experimental·P J JonesC L Birmingham
Sep 1, 1987·Clinical Endocrinology·L L Ng, T D Hockaday
Sep 1, 1988·Diabetes/metabolism Reviews·E Jéquier, Y Schutz
Jan 1, 1986·Diabetes/metabolism Reviews·K R Segal, F X Pi-Sunyer
Jun 1, 1981·Bioscience Reports·M C SugdenC E Marshall
Feb 4, 1998·Obesity Research·L de Jonge, G A Bray
May 18, 2016·Journal of Physical Therapy Science·Ryota Asahara, Masahiro Yamasaki
Jan 1, 1995·Behaviour Research and Therapy·J Wardle
Mar 1, 1993·Diabetic Medicine : a Journal of the British Diabetic Association·S RobinsonD G Johnston
Jan 1, 1990·Clinical Physiology·A ThörneJ Wahren
Jul 1, 1988·The British Journal of Nutrition·P I Mansell, I A MacDonald
Sep 1, 1992·JPEN. Journal of Parenteral and Enteral Nutrition·O RiggioL Capocaccia
Jan 1, 1987·American Journal of Health Promotion : AJHP·J D Nash
May 1, 1985·European Journal of Pediatrics·D MolnárJ Mestyán
Jan 1, 1992·European Journal of Applied Physiology and Occupational Physiology·V L KatchA P Rocchini
Mar 15, 1997·Annals of the New York Academy of Sciences·L JanskýM Simecková
Apr 1, 1989·Acta diabetologica latina·C De PaloG Federspil
Feb 15, 1986·British Medical Journal·P J IllingworthT E Isles
Jun 20, 1987·British Medical Journal·P J IllingworthT E Isles
Aug 30, 1986·British Medical Journal·A B Mason, J M Willoughby
Aug 30, 1986·British Medical Journal·R T Jung, W P James
May 28, 1983·British Medical Journal·J S Garrow
Jul 1, 2006·Journal of Biosciences·T RajA V Kurpad
Sep 1, 1982·The Proceedings of the Nutrition Society·H B Stoner
Jun 1, 1982·The Proceedings of the Nutrition Society·G R Hervey, G Tobin
Jul 1, 1991·Clinical Endocrinology·R T Jung, P Chong
Dec 13, 1984·The New England Journal of Medicine·J Himms-Hagen
Jan 1, 1987·Annals of the New York Academy of Sciences·E Jéquier
Oct 7, 2004·Journal of the American College of Nutrition·Thomas L Halton, Frank B Hu
Mar 1, 1992·The British Journal of Nutrition·L S PiersP S Shetty
Jun 5, 1999·The American Journal of Clinical Nutrition·A AstrupB Buemann
Mar 1, 1992·The British Journal of Nutrition·L S PiersP S Shetty

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.